• Lipo3K Transfection Reagent: Advancing Difficult Cell Transf

  2026-05-09

  Lipo3K Transfection Reagent streamlines high-efficiency delivery of DNA, siRNA, and mRNA, enabling robust gene expression and RNA interference studies in even the most refractory cells. With ultra-low toxicity and a novel enhancer system, it stands as a superior alternative to legacy lipid transfection reagents for advanced molecular research.

• KPT330 Enhances Cas9 Precision by Regulating mRNA Nuclear Ex

  2026-05-08

  This article reviews the recent discovery that KPT330, a selective inhibitor of nuclear export, indirectly improves the specificity of CRISPR-Cas9 genome and base editing by modulating Cas9 mRNA export. The findings suggest a novel, non-protein-based approach for enhancing gene editing precision in mammalian cells, with important methodological and translational implications.

• Cy5 TSA Fluorescence System Kit: Spatial Proteome Mapping Re

  2026-05-08

  Explore how the Cy5 TSA Fluorescence System Kit elevates spatial proteome mapping with horseradish peroxidase catalyzed tyramide deposition, providing unmatched sensitivity and specificity for advanced immunohistochemistry and in situ hybridization workflows.

• QRICH1 Drives HMGB1 Secretion in HBV-Linked Hepatic Fibrosis

  2026-05-07

  This study identifies QRICH1 as a key effector of endoplasmic reticulum (ER) stress, enhancing the translocation and secretion of HMGB1 in hepatocytes during HBV-induced hepatic fibrosis. The findings reveal molecular mechanisms connecting viral infection, ER stress, and pro-fibrotic signaling, with implications for targeting QRICH1-mediated pathways in liver disease.

• Dacarbazine: Applied Workflows in Cancer DNA Damage Assays

  2026-05-07

  Dacarbazine remains a cornerstone antineoplastic chemotherapy drug for in vitro and translational cancer research, enabling precise interrogation of DNA alkylation mechanisms and cytotoxic responses. This article delivers actionable protocols, troubleshooting insights, and comparative context to help labs leverage Dacarbazine’s unique properties for reproducible, high-impact results.

• EZ Cap™ Cas9 mRNA (m1Ψ): Precision Genome Editing Reagent

  2026-05-06

  EZ Cap™ Cas9 mRNA (m1Ψ) is a next-generation mRNA with Cap1 structure, optimized for high-efficiency genome editing in mammalian cells. Its modified cap and N1-Methylpseudo-UTP composition enhance mRNA stability and minimize immune activation, supporting reproducible, low-toxicity CRISPR-Cas9 workflows.

• Cell Cycle Assay Kit: Precision Analysis of G0/G1, S, and G2

  2026-05-06

  The Cell Cycle Assay Kit (Catalog No. K2263) empowers researchers to dissect cell cycle phases G0/G1, S, and G2/M with quantitative accuracy using propidium iodide staining and optimized RNase A treatment. Streamline your cancer research cell proliferation and apoptosis detection workflow with reproducible, high-fidelity data and proven troubleshooting strategies.

• Vincristine Sulfate: Strategic Insights for Translational On

  2026-05-05

  This thought-leadership article examines vincristine sulfate’s mechanistic and translational value as a microtubule disrupter in cancer research. By integrating biological rationale, experimental validation, competitive positioning, and forward-looking strategies, it provides translational researchers with actionable guidance and a critical edge beyond conventional product summaries.

• L-NMMA Acetate in Periodontal Regeneration: NOS Inhibition R

  2026-05-05

  Explore how L-NMMA acetate unlocks precision modulation of the nitric oxide pathway in dental and regenerative research. This article uncovers novel, evidence-based applications of N(G)-monomethyl-L-arginine acetate, going beyond standard inflammation and cardiovascular models.

• Decitabine (5-Aza-2'-deoxycytidine): Translational Insights

  2026-05-04

  Explore the multifaceted role of Decitabine (5-Aza-2'-deoxycytidine) in cancer epigenetics, focusing on practical assay design, toxicity, and gene reactivation mechanisms. This article provides advanced scientific analysis and actionable guidance, uniquely grounded in foundational toxicology data.

• Vincristine Sulfate: Applied Workflows for Cancer Research S

  2026-05-04

  Vincristine sulfate from APExBIO empowers cancer researchers with gold-standard protocol flexibility, superior solubility, and robust antitumor efficacy. This guide translates bench-to-bedside insights into actionable workflows, troubleshooting tactics, and advanced comparative strategies for acute lymphoblastic leukemia, lymphoma, and brain tumor models.

• KPT330 Enhances Precision of CRISPR-Cas9 by Regulating mRNA

  2026-05-03

  The referenced study identifies KPT330, a clinically approved SINE compound, as an indirect and irreversible modulator of CRISPR-Cas9 activity. By selectively interfering with Cas9 mRNA nuclear export, KPT330 improves genome- and base-editing specificity, offering a new strategy for precise gene editing applications.

• (+)-Bicuculline: Technical Guide for GABAA Antagonist Protoc

  2026-05-02

  (+)-Bicuculline is a research-grade GABAA receptor antagonist used to dissect inhibitory neurotransmission and study synaptic NMDA receptor signaling. It is intended for controlled laboratory experiments, not for diagnostic or clinical use. Proper handling of solubility and storage is essential for reliable results.

• KPT330 Enhances CRISPR-Cas9 Specificity via mRNA Nuclear Exp

  2026-05-01

  The referenced study identifies KPT330 as a small molecule that enhances the specificity of CRISPR-Cas9 genome and base editing by selectively inhibiting Cas9 mRNA nuclear export. This mechanism offers a new approach to reduce off-target effects in genome editing applications, expanding the toolkit for precise genetic engineering.

• Irinotecan (CPT-11): Mechanistic Insights and Translational

  2026-05-01

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Irinotecan (CPT-11) in colorectal cancer research. Integrating recent findings on DNA damage, apoptosis induction, and emerging challenges such as chemotherapy-induced steatohepatitis, the article offers actionable guidance for researchers using APExBIO Irinotecan (A5133). It bridges foundational mechanisms with evolving demands in preclinical modeling, competitive benchmarking, and strategic foresight for next-generation translational studies.

11105 records 1/741 page Next 12345 下5页 Last page